The Benefit-Risk SIG was set up at the start of 2012 to help support those involved in this fast evolving area.
The main aims of the SIG are:
Currently the SIG has subgroups working on:
We also develop relevant training in the area of structured Benefit-Risk as needed.
If you have an interest in being involved in this SIG, or have an interesting case study or experience of carrying out a structured Benefit-Risk assessment to share, please contact Maria Costa (email: maria_j.costa@novartis.com)
Our BLOG can be found under www.benefit-risk-assessment.com. It is a great source of information for all things Benefit-Risk related: upcoming conferences, journal publications, training, and much more.
The UKCRC CTU statisticians’ operations group in collaboration with Imperial College London are hosting a one-day consensus meeting to develop recommendations to support researchers in their choice of visualisations for adverse event data in RCT publications.
Have you ever wondered what it takes to be successful as a statistician or data scientist in the healthcare/pharma industry and what can give you the extra edge to develop your career? Come and listen to these industry leaders views on how to be successful and the advantages of being part of the PSI community.
The ITIT course will take 25 delegates new to the industry on a complete drug development experience from discovery to marketing. They will visit 6 companies from October 2020 to July 2021 to learn about 6 topics from experts in their field. The ITIT course will have 3 sessions in continental Europe and 3 - 4 sessions in the UK. It promises to be a truly memorable course.
This course is aimed at Statisticians and Programmers experienced in SAS, but little or no experience with R. An Introduction to R studio and the R language, statistical graphics, programming statistical models, simulations and more…
PSI Toxicology SIG workshop – 24th and 25th November 2020 The Toxicology SIG provides a forum for statisticians working in regulatory/investigative toxicology, as well as most other pre-clinical areas, to discuss issues and interact with one another. This 1.5-day workshop will involve approximately 20 statisticians, focusing on discussions around “best practice” in the statistical analysis of various data types. The afternoon of Day 1 will include a 4.5 hour Bayesian training course focused towards applications in toxicology/pre-clinical, provided by Prof. Dr. Katja Ickstadt and is included in the workshop fee. The cost will be £270 including VAT per delegate, inclusive of food and one night’s accommodation (and the training course). The workshop is being held at the Crowne Plaza Hotel, Heathrow. The agenda and topics that will be discussed are yet to be finalised, but please get in touch with gareth.thomas@covance.com if you have suggestions. Full details will be circulated in the coming weeks.
Covance are currently recruiting for 3 Principal / Senior Principal Biostatisticians in two different departments.
Global pharma company Novo Nordisk are right now looking for a Statistical Director to drive the Health Technology Assessment agenda in the Biostatistical Centre of Expertise in their office just outside Copenhagen.
Would you like to be a part of a Statistical and Programming group, who have direct strategic impact on drug development, playing a key role in getting medicines to patients?
